Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

stangen pharmaceuticals philippines inc. - meropenem (as trihydrate) - powder for solution for i.v. injection - 1g

Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

i.e. medica, inc. - meropenem (as trihydrate) - powder for injection (i.v.) - 1g

Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

jlt pharma, inc.; distributor: uni-pharma phils., inc. - meropenem (as trihydrate) - powder for injection (im/iv) - 1g

Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

pfizer, inc - meropenem (as trihydrate) - powder for solution for injection/infusion - 500mg

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

par pharmaceutical, inc. - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem 500 mg in 20 ml

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

cardinal health - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem 500 mg in 10 ml

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

wg critical care, llc - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem for injection, usp is indicated for the treatment of complicated skin and skin structure infections (csssi) due to staphylococcus aureus (methicillin-susceptible isolates only), streptococcus pyogenes, streptococcus agalactiae, viridans group streptococci, enterococcus faecalis (vancomycin-susceptible isolates only), pseudomonas aeruginosa, escherichia coli, proteus mirabilis, bacteroides fragilis, and peptostreptococcus species. meropenem for injection, usp is indicated for the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, escherichia coli , klebsiella pneumoniae , pseudomonas aeruginosa , bacteroides fragilis , b. thetaiotaomicron , and peptostreptococcus species. meropenem for injection, usp is indicated for the treatment of bacterial meningitis caused by haemophilus influenzae , neisseria meningitidis and penicillin-susceptible isolates of streptococcus pneumoniae . meropenem for injection, usp has been found to be effective in eliminating con

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

wg critical care, llc - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem for injection, usp is indicated for the treatment of complicated skin and skin structure infections (csssi) due to staphylococcus aureus (methicillin-susceptible isolates only), streptococcus pyogenes, streptococcus agalactiae, viridans group streptococci, enterococcus faecalis (vancomycin-susceptible isolates only), pseudomonas aeruginosa, escherichia coli, proteus mirabilis, bacteroides fragilis, and peptostreptococcus species. meropenem for injection, usp is indicated for the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, escherichia coli , klebsiella pneumoniae , pseudomonas aeruginosa , bacteroides fragilis , b. thetaiotaomicron , and peptostreptococcus species. meropenem for injection, usp is indicated for the treatment of bacterial meningitis caused by haemophilus influenzae , neisseria meningitidis and penicillin-susceptible isolates of streptococcus pneumoniae . meropenem for injection, usp has been found to be effective in eliminating con

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

fresenius kabi usa, llc - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem for injection, usp (i.v.) is indicated for the treatment of complicated skin and skin structure infections (csssi) due to staphylococcus aureus (methicillin-susceptible isolates only), streptococcus pyogenes, streptococcus agalactiae, viridans group streptococci, enterococcus faecalis (vancomycin-susceptible isolates only), pseudomonas aeruginosa, escherichia coli, proteus mirabilis, bacteroides fragilis, and peptostreptococcus species. meropenem for injection, usp (i.v.) is indicated for the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, escherichia coli , klebsiella pneumoniae , pseudomonas aeruginosa , bacteroides fragilis , b. thetaiotaomicron , and peptostreptococcus species. meropenem for injection, usp (i.v.) is indicated for the treatment of bacterial meningitis caused by haemophilus influenzae , neisseria meningitidis and penicillin-susceptible isolates of streptococcus pneumoniae . meropenem for injection, usp (i.v.) has been found to be

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

fresenius kabi usa, llc - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem for injection, usp (i.v.) is indicated for the treatment of complicated skin and skin structure infections (csssi) due to staphylococcus aureus (methicillin-susceptible isolates only), streptococcus pyogenes, streptococcus agalactiae, viridans group streptococci , enterococcus faecalis (vancomycin-susceptible isolates only), pseudomonas aeruginosa, escherichia coli, proteus mirabilis, bacteroides fragilis, and peptostreptococcus species. meropenem for injection, usp (i.v.) is indicated for the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, escherichia coli , klebsiella pneumoniae , pseudomonas aeruginosa , bacteroides fragilis , b. thetaiotaomicron , and peptostreptococcus species. meropenem for injection, usp (i.v.) is indicated for the treatment of bacterial meningitis caused by